Patients with primary invasive breast cancer ( clinically lymph node negative and less than or equal to @ cm in size ) were randomized before surgery for completion axillary lymph node dissection ( arm A-standard treatment ) or axillary nodal irradiation ( arm B-investigational treatment ) .